Neurostimulation Technology and Global Markets Report 2023: 2020-2022 Data, Estimates for 2023, and CAGR Projections through 2028 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Neurostimulation: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
This report provides a comprehensive study of the global market for neurostimulation technologies and devices. It provides a detailed description of the different types of neurostimulation technologies and devices (invasive and noninvasive) and their current and historical market revenues.
The human nervous system works as the chief commander of the human body. The medical science community has long believed that it has huge potential in treatment of human body disorders. Neurostimulation technology involves the alteration or modulation of nerves. Neurostimulation devices deliver electrical current or magnetic impulses directly to nerves in order to modify their activity.
Over the past 25 to 30 years, neurostimulation has emerged as one of the most dynamic fields of therapy, and has been actively investigated for treatment of a range of clinical conditions including chronic pain, movement disorders (Parkinson's disease, tremor, dystonia and others), epilepsy, psychiatric disorders, functional restoration, cardiovascular disorders, gastrointestinal disorders and genitourinary disorders. It is also said to consist of "drug-free solutions." Currently, the potential of neurostimulation technology is actively being explored for other clinical conditions including obesity, tinnitus and central nerve system disorders.
Given the vast size of the potential treatment population and the many ongoing scientific discoveries and technological advances in neurostimulation technologies, the market for neurostimulation devices market is poised for significant growth. Other factors expected to aid in the market boom include many countries' growing elderly populations and increasing trends toward the use of nondrug therapies, greater expectations for quality of life, and improved patient attitudes toward receiving medical attention.
Neurostimulation technologies represent a cutting-edge field in neuroscience and medical science, aiming to modulate the activity of the nervous system to treat a wide range of neurological and neuropsychiatric disorders. These innovative techniques involve the application of electrical, magnetic or optogenetic stimuli to specific areas of the brain or nervous system, offering the potential to alleviate symptoms, restore lost function and enhance cognitive capabilities.
Neurostimulation is based on the concept of neuromodulation, where electrical signals are applied to neurons to alter their activity and influence neural networks. Neurons communicate through electrical impulses, and by selectively stimulating or inhibiting specific neural populations, neuroscientists and clinicians can modulate brain function.
This report also covers in detail the therapeutic applications of neurostimulation technologies and devices, including chronic pain, Parkinson's disease, epilepsy, urinary and fecal incontinence, obstructive sleep apnea, essential tremor, obsessive compulsive disorder, major depressive disorder/clinical depression and others. An in-depth analysis of the global market for neurostimulation technologies and devices includes historical data and market projections by device type, therapeutic application and region.
Report Includes
Estimation of the market size and analyses of market trends, with data from 2020 to 2022, estimates for 2023 and projection of CAGR through 2028
Description of Dorsal Root Ganglion (DRG) neurostimulator system and discussion on approved indications of stimulation therapy for various diseases
Detailed description of various types of stimulation such as spinal cord stimulation, transcutaneous electrical nerve stimulation, deep brain stimulation, sacral nerve stimulation, Vagus nerve stimulation, hypoglossal nerve stimulation, and transcranial magnetic stimulation; and discussion on their mode of action and advantages
Information on recent therapy improvements and new indications for use, and discussion on alternatives to traditional stimulation therapies
Coverage of ongoing scientific discoveries and technological advances in neurostimulation technologies and insights into marketed and pipeline (R&D) products, product recalls and reimbursement policies
Market share analysis of neurostimulation devices by application, type and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges and opportunities affecting market growth
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
Comprehensive company profiles of major players
Key Attributes:
Report Attribute
Details
No. of Pages
160
Forecast Period
2023 - 2028
Estimated Market Value (USD) in 2023
$8.2 Billion
Forecasted Market Value (USD) by 2028
$11.7 Billion
Compound Annual Growth Rate
7.4%
Regions Covered
Global
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Overview of Neurostimulation
Types of Neurostimulation Technologies
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation (Sns)
Vagus Nerve Stimulation
Hypoglossal Nerve Stimulation
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation (Tms)
Other Neurostimulation Technologies
Therapeutic Applications for Neurostimulation
Chronic Pain Management
Obesity
Psychiatric Disorders
Technological Developments
Mri Compatibility
Rechargeable and Non-Rechargeable Devices
Chapter 4 Market Dynamics
Market Trends
Drivers
Market Restraints
Chapter 5 Market Breakdown by Technology/Device Type
Global Market for Neurostimulation Devices by Type
Spinal Cord Stimulation (Scs) Devices
Transcutaneous Electrical Nerve Stimulation (Tens) Devices
Deep Brain Stimulation (Dbs) Devices
Sacral Nerve Stimulation (Sns) Devices
Vagus Nerve Stimulation (Vns) Devices
Hypoglossal Nerve Stimulation (Hgns) Devices
Market Size and Forecast
Transcranial Magnetic Stimulation (Tms) Devices
Other Types of Neurostimulation Devices
Chapter 6 Market Breakdown by Therapeutic Application
Global Market for Neurostimulation Devices by Therapeutic Application
Chronic Pain
Essential Tremor
Other Therapeutic Applications
Chapter 7 Market Breakdown by Region
Global Market for Neurostimulation Devices by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 8 Regulatory Structure
Regulatory Framework
U.S.
European Union
Japan
Chapter 9 Key Products and Technologies on the Market
Recent Therapeutic Improvements and New Indications
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation (Sns)
Vagus Nerve Stimulation
Hypoglossal Nerve Stimulation
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation
Other Types of Stimulation
New Indications and Neurostimulation Therapies
Chapter 10 Emerging Technologies and Developments
Emerging Technologies and Developments
Closed-Loop Neurostimulation
Non-Invasive Brain Stimulation Techniques
High-Frequency Stimulation
Magnetic Resonance-Guided Focused Ultrasound
Bioelectronic Medicine
Wireless and Remote-Controlled Devices
Chapter 11 Recent M&A
M&A in the Neurostimulation Technologies Industry
Chapter 12 Competitive Landscape
Company Market Shares by Product Segment
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Hypoglossal Nerve Stimulation Devices
Transcranial Magnetic Stimulation Devices
Transcutaneous Electrical Nerve Stimulation Devices
Recent Industry Activities
Chapter 13 Company Profiles
Aleva Neurotherapeutics Sa
Cochlear Americas
Laborie Inc.
Magstim Inc.
Neuromed Consulting Inc.
Nyxoah Sa
For more information about this report visit https://www.researchandmarkets.com/r/7hblrg
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.